Captor Therapeutics S.A.
CTX | WAR
Overview
Corporate Details
- ISIN(s):
- PLCPTRT00014 (+1 more)
- LEI:
- 259400JHH1S2I2S4O735
- Country:
- Poland
- Address:
- Wrocław Duńska 11, 54-427 Wrocław
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Captor Therapeutics S.A. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel therapeutics using Targeted Protein Degradation (TPD) technology. The company focuses on creating breakthrough drugs for diseases with high unmet medical needs, particularly in oncology and autoimmune disorders. Captor utilizes its proprietary Optigrade™ platform, a drug discovery engine that integrates protein engineering, structural biology, molecular modelling, and CRISPR/Cas9 genome editing. This platform enables the rapid identification and development of drug candidates that can target previously 'undruggable' proteins, offering new treatment options for severe conditions.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Captor Therapeutics S.A..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-27 20:00 |
Share Issue/Capital Change
Dopuszczenie i wprowadzenie do obrotu giełdowego akcji zwykłych na okaziciela s…
|
Polish | 779 bytes | |
| 2025-08-25 19:35 |
Share Issue/Capital Change
uchwała
|
Polish | 2.6 MB | |
| 2025-08-25 19:35 |
Share Issue/Capital Change
Podjęcie uchwały przez Zarząd Spółki w sprawie emisji akcji w ramach docelowego…
|
Polish | 1005 bytes | |
| 2025-08-14 23:21 |
Registration Form
Komunikat Krajowego Depozytu Papierów Wartościowych S.A. w sprawie warunkowej r…
|
Polish | 1.2 KB | |
| 2025-08-11 17:01 |
Director's Dealing
załącznik
|
Polish | 4.3 KB | |
| 2025-08-11 17:01 |
Related Party Transaction
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 892 bytes | |
| 2025-08-08 14:15 |
Report Publication Announcement
Zmiana terminu publikacji raportu okresowego za pierwsze półrocze 2025 roku - C…
|
Polish | 829 bytes | |
| 2025-08-07 18:23 |
Transaction in Own Shares
Zawarcie umowy nieodpłatnego nabycia akcji własnych przez Spółkę w celu realiza…
|
Polish | 2.2 KB | |
| 2025-07-04 18:22 |
Director's Dealing
treść powiadomienia
|
Polish | 9.2 KB | |
| 2025-07-04 18:22 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 702 bytes | |
| 2025-07-02 17:08 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających na Zwyczajnym Walnym Zgromadzeniu Spółki 26 c…
|
Polish | 2.0 KB | |
| 2025-06-26 17:18 |
Board/Management Information
oświadczenie
|
Polish | 205.4 KB | |
| 2025-06-26 17:18 |
Board/Management Information
życiorys (PL)
|
Polish | 164.7 KB | |
| 2025-06-26 17:18 |
Board/Management Information
życiorys
|
English | 175.3 KB | |
| 2025-06-26 17:18 |
Post-Annual General Meeting Information
treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie
|
Polish | 469.4 KB |
Automate Your Workflow. Get a real-time feed of all Captor Therapeutics S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Captor Therapeutics S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
